Related Experiment Video
Updated: Sep 13, 2025
06:07
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.7K
Summary
Parkinson disease (PD) management has advanced with new treatments for motor symptoms and diagnostic tools like alpha-synuclein skin biopsy. While quality of life can improve, no cure currently halts PD progression.
Area of Science:
- Neurology
- Neuroscience
Background:
- Parkinson disease (PD) is a progressive neurodegenerative disorder with increasing prevalence, particularly in aging populations.
- PD presents with diverse motor and nonmotor symptoms impacting patient quality of life.
Purpose of the Study:
- To provide a comprehensive overview of Parkinson disease.
- To discuss clinical presentation, evaluation, risk factors, and current therapeutic strategies for PD.
Main Methods:
- Review of current literature on Parkinson disease.
- Analysis of recent advancements in pharmacologic and surgical treatments.
- Inclusion of emerging diagnostic techniques.
Main Results:
- New treatments like istradefylline and opicapone, along with subcutaneous drug delivery systems, offer improved management of motor fluctuations in PD.
- Alpha-synuclein skin biopsy is a valuable diagnostic aid for synucleinopathies.
- Symptomatic treatments and surgical interventions can enhance quality of life for individuals with PD.
Conclusions:
- Current interventions focus on symptomatic relief and quality of life improvement in Parkinson disease.
- Despite advances, there is no established treatment to modify the underlying progression of PD.
Related Concept Videos
01:15Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:37Neural Regulation
40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K
01:19Brainstem
3.1K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.1K
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:30Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33